Clinical Scorecard: Integrating Double-Balloon Enteroscopy into the Diagnostic Pathway for Suspected Small Bowel Crohn’s Disease: A Retrospective Study from a Tertiary Care Center

At a Glance

Key Highlights

• SBCE established or excluded inflammatory bowel disease in 70% of patients.
• DBE confirmed Crohn’s disease in 21% of patients undergoing the procedure.
• DBE referral was predicted by increasing age and diagnostic uncertainty on SBCE.
• SBCE was the initial investigation in 90.8% of cases.
• DBE should be reserved for cases needing histological confirmation or therapeutic intervention.

Guideline-Based Recommendations

Diagnosis

• Use SBCE as the first-line investigation for suspected small bowel Crohn’s disease.
• Consider DBE for diagnostic clarification or when histological confirmation is needed.

Management

• DBE can be used for therapeutic interventions such as stricture dilatation.

Monitoring & Follow-up

• Monitor for capsule retention in patients with suspected stricturing disease.

Risks

• Capsule retention rates range from 0–5.4% in suspected Crohn’s disease.

Patient & Prescribing Data

Patients with suspected small bowel Crohn’s disease referred for SBCE.

DBE may lead to changes in clinical management for a significant proportion of patients.

Clinical Best Practices

• Utilize SBCE for initial assessment before considering DBE.
• Ensure appropriate patient selection to maximize diagnostic yield.

References

• American College of Gastroenterology Guidelines